Source: International Congress 2017 – New immune markers for asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Kovach (Solna, Sweden). Late Breaking Abstract - IL-36 receptor agonists contribute to a pro-inflammatory milieu in smokers with and without COPD. 4846

Member's Comments

No comment yet.

Related content which might interest you: Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Late Breaking Abstract - Bedaquiline enhances receptor phagocytosis and decreases IL1b production in human pro-inflammatory macrophages Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021 Late Breaking Abstract - IL-33 drives influenza-induced exacerbations of asthma by halting anti-viral and Th1 responses Source: International Congress 2017 – Animal models of asthma and allergies Year: 2017 Late Breaking Abstract: IL-17 inhibits IL-23 release during airway inflammation Source: Annual Congress 2010 - Lung cell biology and immunology Year: 2010 Late Breaking Abstract - Calcium-sensing receptor activators increased in the sputum of idiopathic pulmonary fibrosis patients Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Aerobic training reverses the inhibition in the expression of glucocorticoid receptors and decreases the Th2 allergic inflammation in asthma model Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013 Late Breaking Abstract - SARS-CoV-2 induces hyperinflammation in human macrophages via TLR4 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021 Late Breaking Abstract - Role of Muscarinic M3 receptors in bronchial remodelling of severe asthma Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 LATE-BREAKING ABSTRACT: A novel role for CCR3 in promoting airways hyperreactivity; Role for CCR3-muscarinic M3 receptor heterodimers Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015 Late Breaking Abstract - Enhanced IL-33 response in differentiated human TH2 cells carrying the IL-1RL1 asthma risk genotype Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials Year: 2021 Chemokines receptors expression in induced sputum in COPD and asthma Source: Annual Congress 2003 - Activation, migration and death of immune cells Year: 2003 WNT-4 regulates pro-inflammatory responses driven by epithelial-mesenchymal cross-talk Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Late Breaking Abstract - The inflammasome cluster is linked with airway NETosis in COPD Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair Year: 2021 Anticholinergic treatment does not affect toll-like receptor 3-induced antiviral immune response in COPD bronchial epithelial cells Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Changes in the populations of blood T-lymphocytes containing chemokine receptors in non-smoking patients with COPD Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung Year: 2013 IL-33 augments rhinovirus-induced type 2 immune responses in asthma via selective upregulation of one chain of the IL-33 receptor. Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 Decreased PTEN amplifies PI3K signaling and enhances pro-inflammatory cytokine release in COPD Source: International Congress 2016 – Studies in airway cell biology Year: 2016 The role of chemokine receptors in the aberrant migration of COPD neutrophils Source: International Congress 2014 – Cell biology 2014 Year: 2014 Induced sputum cytokines and chemokines and mechanistic pathways in adult asthma phenotypes Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 Elevated IL-10 level but not cysteinyl leukotrienes (CysLT) release from leukocytes in vitro correlates with good response to treatment with montelukast in asthmatic patients Source: International Congress 2014 – Asthma and COPD management Year: 2014